By genetic engineering, we
can over-express the key enzymes involved in biosynthesis
of artemisinin, such as FPS and AMS, or inhibit the enzymes
involved in other pathways competing for it’s precursors,
such as SQS, to obtain transgenic high-yield A. annua. It is
thought to be one of the most reasonable approaches to
enhance the production of artemisinin [4].